Spotting symptoms early: the importance of early diagnosis
Cancer Research UK have been highlighting the importance of screening [...]
Health-related quality of life with belzutifan versus everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
Safe Sick Pay Campaign Update
For months we’ve been campaigning with workers, The Centre for [...]
FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans
The Food and Drug Administration (FDA) in America has accepted [...]
Kidney cancer research highlights from ASCO GU 2025
Every year, researchers from around the world gather at a [...]
Spotting symptoms early: the importance of early diagnosis
Cancer Research UK have been highlighting the importance of screening [...]
Cancer Research UK – 74,000 cancer patients not treated on time in 2024
A new analysis by Cancer Research UK revealed that in [...]
New personalised cancer vaccine shows promise for advanced kidney cancer
A new personalised cancer vaccine has shown promising anti-tumour immunity [...]
Belzutifan approved in Europe for advanced kidney cancer and VHL disease
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for [...]
